Skip to main content
. 2022 May 9;12:835027. doi: 10.3389/fonc.2022.835027

Table 3.

Combination index(CI) for different drug combinations in MDA-MB-231, MCF7 cells.

ST08+Drug CI for MDA-MB-231 CI for MCF7
Cisplatin Synerism (30nM ST08+2.5 μM) Synergism (60nM ST08+ 2μM)
Olaprib Synerism (20nM ST08+1μM) Synergism (40nM ST08+5 μM)
Doxorubicin Additive (20nM ST08+0.5μM) Additive (40nM ST08+10 μM)